Regulatory watch: Where do new medicines originate from in the EU?

Nature Reviews Drug Discovery

Volumn 13, Issue 2, 2014, Pages 92-93

  Lincker, Helene ^a   Ziogas, Constantinos ^a   Carr, Melanie ^a   Porta, Nuria ^a   Eichler, Hans Georg ^a  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; ORPHAN DRUG;

DRUG APPROVAL; DRUG DATABASE; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; EUROPEAN UNION; GEOGRAPHIC ORIGIN; GOVERNMENT REGULATION; LICENSING; PRODUCT DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; SHORT SURVEY; DRUG DEVELOPMENT; EUROPE; PRIORITY JOURNAL; REVIEW;

DRUG APPROVAL; DRUG INDUSTRY; EUROPEAN UNION; MARKETING OF HEALTH SERVICES; ORPHAN DRUG PRODUCTION; PHARMACEUTICAL PREPARATIONS;

EID: 84893275211     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4232     Document Type: Short Survey

References (1)

1. doi:10.1038/nrd4232